Table 1.

Characteristics of 85 patients who developed lymphoid neoplasms after ALL diagnosis, without prior HSCT

CharacteristicTotal (n = 85)LBL (n = 22)Mature B-cell lymphoproliferations (n = 56)P value: Mature B vs LBL
Sex, n (%)     
Male 52 (61) 14 (64) 33 (59) .79 
Female 33 (39) 8 (36) 23 (41) 
Age at ALL diagnosis, n (%)     
<10 years 67 (79) 20 (91) 43 (77) .21 
≥10 years 18 (21) 2 (9) 13 (23)  
Age at lymphoid neoplasm diagnosis, n (%)     
<10 years 49 (58) 11 (50) 35 (63) .32 
≥10 years 36 (42) 11 (50) 21 (37)  
Leukemia lineage, n (%)     
B-ALL 64 (75) 16 (73) 44 (79) .12 
T-ALL 12 (14) 5 (23) 5 (9) 
Unknown 9 (11) 1 (4) 7 (12) 
Interval between leukemia and lymphoid neoplasm diagnoses, years     
Median (IQR) 2.28 (1.58-4.01) 3.7 (2.18-9.35) 2.2 (1.45-2.96) <.01 
Lymphoid neoplasm diagnosed during maintenance or within 6 months of its completion, n (%) 59 (69) 8 (36) 46 (82) <.01 
Lymphoid neoplasm diagnosed >6 months of maintenance cessation, n (%) 26 (31) 14 (64) 10 (18)  
CharacteristicTotal (n = 85)LBL (n = 22)Mature B-cell lymphoproliferations (n = 56)P value: Mature B vs LBL
Sex, n (%)     
Male 52 (61) 14 (64) 33 (59) .79 
Female 33 (39) 8 (36) 23 (41) 
Age at ALL diagnosis, n (%)     
<10 years 67 (79) 20 (91) 43 (77) .21 
≥10 years 18 (21) 2 (9) 13 (23)  
Age at lymphoid neoplasm diagnosis, n (%)     
<10 years 49 (58) 11 (50) 35 (63) .32 
≥10 years 36 (42) 11 (50) 21 (37)  
Leukemia lineage, n (%)     
B-ALL 64 (75) 16 (73) 44 (79) .12 
T-ALL 12 (14) 5 (23) 5 (9) 
Unknown 9 (11) 1 (4) 7 (12) 
Interval between leukemia and lymphoid neoplasm diagnoses, years     
Median (IQR) 2.28 (1.58-4.01) 3.7 (2.18-9.35) 2.2 (1.45-2.96) <.01 
Lymphoid neoplasm diagnosed during maintenance or within 6 months of its completion, n (%) 59 (69) 8 (36) 46 (82) <.01 
Lymphoid neoplasm diagnosed >6 months of maintenance cessation, n (%) 26 (31) 14 (64) 10 (18)  

Data from the Ponte di Legno Childhood ALL Working Group study.

IQR, interquartile range.

The total number of patients includes patients with LBL (n = 22) and mature B-cell lymphoproliferations (n = 56) in addition to patients with peripheral T-cell lymphoma (n = 2) and NHL with no further classification (n = 5), as described in more detail in “Results”.

Fisher exact test or Brown-Mood median test.

or Create an Account

Close Modal
Close Modal